Literature DB >> 2695154

Characteristics of persistent ovarian masses in asymptomatic women.

V Bhan1, N Amso, M I Whitehead, S Campbell, P Royston, W P Collins.   

Abstract

Persistent ovarian masses have been found in a substantial proportion of 5479 self-selected asymptomatic women who were screened for early ovarian neoplasia. Each woman was scheduled to undergo three ultrasound screens (consisting of 1-12 scans) to detect regressing and non-regressing masses. A total of 14,594 screens (15,977 scans) was performed. The average interval between successive screens was 595 days (range 214-1134 days). Overall, 650 screens (4.4%; 10.1% of women) produced a positive result which became negative with successive scans (four times more frequently in pre- than naturally postmenopausal women), and 338 screens (2.3%; 5.9% of women) had a final positive result (at least one ovary that was grossly abnormal or contained a persistent mass). Biopsies were taken from 336 ovaries (89% of total, 271 women). Overall, 134 tumour-like conditions and 119 benign tumours were identified. The detection rate of tumour-like conditions was 1.5 times higher in premenopausal than naturally postmenopausal women, whereas the proportion of tumours to normal ovaries was similar in both groups. Overall, 51% of tumour-like conditions and 70% of all tumours were detected at screen 1. Four women had metastatic ovarian cancer (three at screen 1, one at screen 2; two were bilateral). Five women (0.1%) had a primary malignant tumour (two at screen 1, three at screen 2; four were stage 1a and one was stage 1b). All women are being monitored to obtain additional information about the significance of the findings.

Entities:  

Mesh:

Year:  1989        PMID: 2695154     DOI: 10.1111/j.1471-0528.1989.tb06299.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  1 in total

1.  Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

Authors:  T H Bourne; S Campbell; K M Reynolds; M I Whitehead; J Hampson; P Royston; T J Crayford; W P Collins
Journal:  BMJ       Date:  1993-04-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.